Floatz logo

Gonadotropin-Releasing Hormone

Osteoporosis

Radiation Therapy Oncology GroupPhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Osteoporosis cohort.

Asset / SponsorPhaseRating
RISEDRONIC ACID
Susan L. Greenspan
Phase 4BBB
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BBB
VITAMIN D
Benha University
Phase 4BBB
ALENDRONIC ACID
University College Dublin
Phase 4BBB
Calcium
Benha University
Phase 4BBB

View all 50 →

Same molecule, other indications

Gonadotropin-Releasing Hormone is also rated in:

anovulationDormant
BB
Indicative ·
65 / 100
View asset →
infertility disorderDormant
BB
Indicative ·
65 / 100
View asset →
prostate cancerDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →